๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Single-dose intraperitoneal radioimmunotherapy with the murine monoclonal antibody I-131 MOv18: Clinical results in patients with minimal residual disease of ovarian cancer

โœ Scribed by F. Crippa; G. Bolis; E. Seregni; N. Gavoni; G. Scarfone; C. Ferraris; G.L. Buraggi; E. Bombardieri

Book ID
116166131
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
621 KB
Volume
31
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Immunoscintigraphy with 131I-labelled mo
Immunoscintigraphy with 131I-labelled monoclonal antibodies HMFG2 and HMFG1 F(ab')2 versus abdominal CT scan in the detection of residual disease in ovarian cancer patients
โœ D. Pectasides; K. Pateniotis; L. Tzimis; X. Trapalli; P. Natsis; P. Arapantoni; ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 514 KB

3'I-labelled HMFGl or HMFGl F(ab')2 monoclonal antibody (MAb) was administered intraperitoneally to I S patients with epithelial ovarian cancer who had completed chemotherapy and were in complete or good partial remission. Each patient received 2-3 mCi. Patients were scanned immediately after and un